Jane Street
ASND icon

Jane Street’s Ascendis Pharma A/S ASND Stock Holding History

Jane Street’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.6M Buy
69,900
+3,500
+5% +$818K ﹤0.01% 2217
2026
Q1 		$15.2M Sell
66,400
-7,200
-10% -$1.61M ﹤0.01% 2049
2025
Q4 		$15.7M Hold
73,600
– – ﹤0.01% 1827
2025
Q3 		$14.6M Buy
73,600
+45,200
+159% +$8.43M ﹤0.01% 1965
2025
Q2 		$4.9M Buy
28,400
+5,800
+26% +$945K ﹤0.01% 3019
2025
Q1 		$3.52M Buy
22,600
+20,000
+769% +$2.86M ﹤0.01% 3469
2024
Q4 		$358K Sell
2,600
-10,200
-80% -$1.34M ﹤0.01% 7437
2024
Q3 		$1.91M Buy
12,800
+8,300
+184% +$1.12M ﹤0.01% 4572
2024
Q2 		$614K Sell
4,500
-200
-4% -$27.2K ﹤0.01% 6684
2024
Q1 		$710K Buy
4,700
+2,000
+74% +$285K ﹤0.01% 6057
2023
Q4 		$340K Sell
2,700
-22,100
-89% -$2.2M ﹤0.01% 7427
2023
Q3 		$2.32M Sell
24,800
-17,100
-41% -$1.6M ﹤0.01% 3803
2023
Q2 		$3.74M Buy
41,900
+1,200
+3% +$104K ﹤0.01% 3158
2023
Q1 		$4.36M Sell
40,700
-125,500
-76% -$14.4M ﹤0.01% 2639
2022
Q4 		$20.3M Buy
166,200
+6,300
+4% +$731K 0.01% 998
2022
Q3 		$16.5M Buy
159,900
+95,200
+147% +$9.03M 0.01% 1239
2022
Q2 		$6.01M Sell
64,700
-20,800
-24% -$1.96M ﹤0.01% 2391
2022
Q1 		$10M Buy
85,500
+79,300
+1,279% +$9.18M ﹤0.01% 1984
2021
Q4 		$834K Sell
6,200
-12,900
-68% -$1.92M ﹤0.01% 6271
2021
Q3 		$3.04M Buy
19,100
+11,800
+162% +$1.61M ﹤0.01% 3622
2021
Q2 		$960K Buy
7,300
+1,200
+20% +$160K ﹤0.01% 5926
2021
Q1 		$786K Sell
6,100
-14,900
-71% -$2.26M ﹤0.01% 5931
2020
Q4 		$3.5M Buy
21,000
+13,900
+196% +$2.3M ﹤0.01% 2594
2020
Q3 		$1.1M Sell
7,100
-5,300
-43% -$762K ﹤0.01% 3946
2020
Q2 		$1.83M Buy
+12,400
New +$1.7M ﹤0.01% 3185

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Jane Street's ASND Position: Q2 2026 in Review

Jane Street opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 187,141 shares worth $49.9M. The stake represents ﹤0.01% of the portfolio and ranks #1431 among its holdings. This is a return to the name: Jane Street previously reported a position in ASND as recently as Q4 2025.

Jane Street first reported a position in ASND in Q3 2017 and has held it in 24 quarters since. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Jane Street held 187,141 shares of Ascendis Pharma A/S worth $49.9M as of Q2 2026.
  • Ascendis Pharma A/S was a new Jane Street position in Q2 2026.
  • Ascendis Pharma A/S made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #1431 holding.
  • Jane Street first reported a position in Ascendis Pharma A/S in Q3 2017 and has held it in 24 quarters since.
  • 313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.